Evidence map›Paper›PMID 36992405›Full record

ArticleViruses2023

Efficient Purification of Cowpea Chlorotic Mottle Virus by a Novel Peptide Aptamer.

Georg Tscheuschner, Marco Ponader, Christopher Raab, Prisca S Weider, Reni Hartfiel, Jan Ole Kaufmann, Jule L Völzke, Gaby Bosc-Bierne, Carsten Prinz, Timm Schwaar and 8 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Peptide Aptamers: Innovative Design and Applications in Pathogen Detection.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Georg TscheuschnerFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.ORCID 0000-0002-2311-1016
Marco PonaderFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Christopher RaabFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Prisca S WeiderFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Reni HartfielFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Jan Ole KaufmannFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Jule L VölzkeFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Gaby Bosc-BierneFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Carsten PrinzFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Timm SchwaarSAFIA Technologies GmbH, 12489 Berlin, Germany.
Paul AndrleFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Henriette BäßlerFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Khoa NguyenFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.
Yanchen ZhuEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, UK.
Antonia S J S MeyEaStCHEM School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, UK.ORCID 0000-0001-7512-5252
Amr MostafaInstitute of Chemistry-Physical Chemistry, University of Potsdam, 14476 Potsdam, Germany.
Ilko BaldInstitute of Chemistry-Physical Chemistry, University of Potsdam, 14476 Potsdam, Germany.ORCID 0000-0002-6683-5065
Michael G WellerFederal Institute for Materials Research and Testing (BAM), 12489 Berlin, Germany.ORCID 0000-0003-2767-2029
Federal Institute For Materials Research and Testing · DEUniversity of Edinburgh · GBUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cowpea chlorotic mottle virus (CCMV) is a plant virus explored as a nanotechnological platform. The robust self-assembly mechanism of its capsid protein allows for drug encapsulation and targeted delivery. Additionally, the capsid nanoparticle can be used as a programmable platform to display different molecular moieties. In view of future applications, efficient production and purification of plant viruses are key steps. In established protocols, the need for ultracentrifugation is a significant limitation due to cost, difficult scalability, and safety issues. In addition, the purity of the final virus isolate often remains unclear. Here, an advanced protocol for the purification of the CCMV from infected plant tissue was developed, focusing on efficiency, economy, and final purity. The protocol involves precipitation with PEG 8000, followed by affinity extraction using a novel peptide aptamer. The efficiency of the protocol was validated using size exclusion chromatography, MALDI-TOF mass spectrometry, reversed-phase HPLC, and sandwich immunoassay. Furthermore, it was demonstrated that the final eluate of the affinity column is of exceptional purity (98.4%) determined by HPLC and detection at 220 nm. The scale-up of our proposed method seems to be straightforward, which opens the way to the large-scale production of such nanomaterials. This highly improved protocol may facilitate the use and implementation of plant viruses as nanotechnological platforms for in vitro and in vivo applications.

Indexed as

Aptamers, PeptideBromovirusNanoparticlesCapsidCapsid ProteinsAptamers, PeptideCapsid Proteinsaffinity chromatographyaffinity extractionCCMV-binding peptidecowpea chlorotic mottle virusmolecular dynamicsnanoparticlesnanotechnologyplant viruspurificationsafety issuesultracentrifugation-free protocolvirus-like particlesvirus production

Identifiers

PMID36992405
PMCPMC10051510
OpenAlexW4323568210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.